Technology | 2019.08.20
Cutting Edge Spine Announces FDA 510(K) Clearance of its EVOL-SI Joint Fusion System; Bringing Novel Super Hydrophilic Nano-technology to the Sacral-iliac Fixation Market
The commercialization of the EVOL-SI system addresses the needs of orthopedic surgeons and neurosurgeons seeking superior clinical outcomes following sacral-iliac surgery.
(PRWeb August 20, 2019)
For more information, please visit
https://www.prweb.com/releases/cutting_e[...]ation_market/prweb16509505.htm
